Novo Nordisk A/S Valor de la empresa
¿Qué es el Valor de la empresa de Novo Nordisk A/S?
El Valor de la empresa de Novo Nordisk A/S es $292.82B
¿Cuál es la definición de Valor de la empresa?
El valor empresarial es una medida del valor de mercado total de una empresa. Se calcula como capitalización de mercado con deuda, interés minoritario y acciones preferentes menos el efectivo total y equivalentes de efectivo.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valor de la empresa de compañías en Sector Health Care en OTC en comparadas con Novo Nordisk A/S
¿Qué hace Novo Nordisk A/S?
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Empresas con valor de la empresa similar a Novo Nordisk A/S
- Comcast Corp tiene Valor de la empresa de $282.58B
- Chevron tiene Valor de la empresa de $284.95B
- Roche AG tiene Valor de la empresa de $287.91B
- Coca-Cola Co tiene Valor de la empresa de $290.54B
- Astrazeneca plc tiene Valor de la empresa de $291.74B
- Merck & Co tiene Valor de la empresa de $292.45B
- Novo Nordisk A/S tiene Valor de la empresa de $292.82B
- Roche AG tiene Valor de la empresa de $293.24B
- Facebook tiene Valor de la empresa de $297.82B
- Bank Of America tiene Valor de la empresa de $300.68B
- Nestlé SA tiene Valor de la empresa de $302.61B
- Netflix tiene Valor de la empresa de $315.31B
- Verizon Communications Inc tiene Valor de la empresa de $319.65B